Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

HKG:1858 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,381	1,409	1,140	1,266	957.19	1,736
Trading Asset Securities	745.06	811.25	745.8	832.02	767.73	-
Cash & Short-Term Investments	2,126	2,220	1,886	2,098	1,725	1,736
Cash Growth	6.48%	17.76%	-10.14%	21.65%	-0.67%	151.68%
Accounts Receivable	255.67	229.71	378.71	441.72	767.39	527.79
Other Receivables	14.74	16.46	17.46	18.61	13.5	4.49
Receivables	270.41	246.17	396.17	460.33	780.89	532.28
Inventory	527.53	535.93	550.84	434.49	259.79	159.68
Prepaid Expenses	-	-	-	-	-	0.01
Other Current Assets	20.92	9.04	7.89	12.16	13.49	19.3
Total Current Assets	2,945	3,012	2,840	3,005	2,779	2,448
Property, Plant & Equipment	480.31	487.32	468.8	465.13	465.27	394.75
Goodwill	-	-	-	13.36	-	-
Other Intangible Assets	114.96	119.79	127.57	136.27	138.17	131.97
Long-Term Deferred Tax Assets	29.41	30.34	26.11	27.63	25.76	22.88
Long-Term Deferred Charges	-	-	-	-	-	0.13
Other Long-Term Assets	21.9	12.19	2.77	1.8	1.48	2.16
Total Assets	3,591	3,661	3,466	3,650	3,410	3,000

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	117.72	160.77	227.85	225.5	237.79	77.66
Accrued Expenses	91.33	115.57	88.04	149.71	120.81	122.48
Current Portion of Leases	2.56	2.68	0.68	1.22	0.69	1.23
Current Income Taxes Payable	8.02	20.31	0.94	12.13	10.88	10.16
Current Unearned Revenue	74.63	82.17	128.56	149.56	85.68	59.54
Other Current Liabilities	155.61	197.11	100.68	138.55	139.96	168.54
Total Current Liabilities	449.87	578.6	546.75	676.67	595.8	439.62
Long-Term Leases	0.5	0.6	0.18	0.53	0.63	-
Long-Term Unearned Revenue	80.35	82.49	86.75	83.79	85.76	85.56
Long-Term Deferred Tax Liabilities	11.03	12.45	10.71	9.33	7.88	5.4
Total Liabilities	541.76	674.14	644.39	770.33	690.07	530.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	383.57	383.57	383.57	383.57	384.28	384.28
Additional Paid-In Capital	1,045	1,045	1,045	1,045	1,051	1,051
Retained Earnings	1,640	1,577	1,404	1,449	1,291	1,034
Treasury Stock	-20.01	-20.01	-12.02	-	-7.14	-
Total Common Equity	3,048	2,985	2,820	2,877	2,720	2,469
Minority Interest	1.51	1.52	1.44	1.77	-	-
Shareholders' Equity	3,050	2,987	2,821	2,879	2,720	2,469
Total Liabilities & Equity	3,591	3,661	3,466	3,650	3,410	3,000

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.06	3.28	0.87	1.75	1.31	1.23
Net Cash (Debt)	2,123	2,217	1,885	2,097	1,724	1,735
Net Cash Growth	6.34%	17.64%	-10.11%	21.64%	-0.67%	152.17%
Net Cash Per Share	5.49	5.78	4.98	5.43	4.48	5.01
Filing Date Shares Outstanding	382.19	382.19	382.7	383.57	383.57	384.28
Total Common Shares Outstanding	382.19	382.19	382.7	383.57	383.57	384.28
Working Capital	2,495	2,433	2,294	2,329	2,183	2,008
Book Value Per Share	7.98	7.81	7.37	7.50	7.09	6.43
Tangible Book Value	2,933	2,866	2,692	2,728	2,582	2,337
Tangible Book Value Per Share	7.67	7.50	7.04	7.11	6.73	6.08
Buildings	264.3	264.3	223.09	223.04	184.58	31.31
Machinery	259.06	252.97	224.08	200.27	179.96	146.51
Construction In Progress	130.7	129.33	156.78	150.14	185.1	281.56

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error